This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guidoboni, M.
Right arrow Articles by Dolcetti, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guidoboni, M.
Right arrow Articles by Dolcetti, R.

 Previous Article

Journal of Virology, February 2005, p. 2643-2649, Vol. 79, No. 4
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.4.2643-2649.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Latent Membrane Protein 1 Deletion Mutants Accumulate in Reed-Sternberg Cells of Human Immunodeficiency Virus-Related Hodgkin's Lymphoma

Massimo Guidoboni,1 Maurilio Ponzoni,2 Laura Caggiari,1 Antonia A. Lettini,1 Luca Vago,3 Valli De Re,4 Annunziata Gloghini,5 Paola Zancai,1 Antonino Carbone,5 Mauro Boiocchi,4 and Riccardo Dolcetti1*

Immunovirology and Biotherapy Unit,1 Division of Experimental Oncology 1, Department of Pre-Clinical and Epidemiological Research,4 Division of Pathology, Centro di Riferimento Oncologico, IRCCS, National Cancer Institute, Aviano, Pordenone,5 Department of Pathology, S. Raffaele H. Scientific Institute,2 Institute of Biomedical Sciences "L. Sacco," Milan, Italy3

Received 16 March 2004/ Accepted 5 July 2004

The origin and biological significance of deletions at the 3' end of the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) gene are still controversial. We herein demonstrate that LMP-1 deletion mutants are highly associated with human immunodeficiency virus-related Hodgkin's lymphoma (HIV-HL) of Italian patients (29 of 31 cases; 93.5%), a phenomenon that is not due to a peculiar distribution of EBV strains in this area. In fact, although HIV-HL patients are infected by multiple EBV variants, we demonstrate that LMP-1 deletion mutants preferentially accumulate within neoplastic tissues. Subcloning and sequencing of the 3' LMP-1 ends of two HIV-HL genes in which both variants were present showed the presence of molecular signatures suggestive of a likely derivation of the LMP-1 deletion mutant from a nondeletion ancestor. This phenomenon likely occurs within tumor cells in vivo, as shown by the detection of both LMP-1 variants in single microdissected Reed-Sternberg cells, and may at least in part explain the high prevalence of LMP-1 deletions associated with HIV-HL.


* Corresponding author. Mailing address: Immunovirology and Biotherapy Unit, Department of Pre-Clinical and Epidemiological Research, Centro di Riferimento Oncologico, IRCCS, National Cancer Institute, via Pedemontana Occidentale 12, 33081 Aviano (PN) Italy. Phone: 39 0434 659660. Fax: 39 0434 659659. E-mail: rdolcetti{at}cro.it.


Journal of Virology, February 2005, p. 2643-2649, Vol. 79, No. 4
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.4.2643-2649.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.